Clarinex-D (Desloratadine / Pseudoephedrine Sulfate) - Summary

CLARINEX-D SUMMARY

CLARINEX-D^® 24 HOUR
(desloratadine 5 mg and pseudoephedrine sulfate, USP 240 mg)
EXTENDED RELEASE TABLETS

CLARINEX-D^® 24 HOUR Extended Release Tablets are light blue oval shaped tablets containing 5 mg desloratadine in the tablet coating for immediate release and 240 mg pseudoephedrine sulfate, USP in the tablet core for extended release.

CLARINEX-D^® 24 HOUR Extended Release Tablets is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis including nasal congestion, in patients 12 years of age and older. CLARINEX-D^® 24 HOUR Extended Release Tablets should be administered when the antihistaminic properties of desloratadine and the nasal decongestant properties of pseudoephedrine are desired (see CLINICAL PHARMACOLOGY).

CLARINEX-D NEWS HIGHLIGHTS

Published Studies Related to Clarinex-D (Desloratadine / Pseudoephedrine)

Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults. [2007.05]

Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis. [2006.11]

Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis. [2005.09]

Increased nasal airflow with budesonide compared with desloratadine during the allergy season. [2005.03]

A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis. [2005.07]

more>>

Clinical Trials Related to Clarinex-D (Desloratadine / Pseudoephedrine)

Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine [Completed]

Study for the Treatment of Chronic Idiopathic Urticaria With High Doses of AERIUS (Study P04849AM4) [Recruiting]

A Study to Assess and Compare the Effects of 5 mg vs. 20 mg Desloratadine on the Development of Cold Urticaria Lesions [Completed]

Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684AM2)(COMPLETED) [Completed]

Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683AM1)(COMPLETED) [Completed]

more>>